xaliproden (SR57746A)

DRUG3 trials

Sponsors

Sanofi

Conditions

Alzheimer DiseaseColorectal CarcinomaColorectal NeoplasmsMetastases

Phase 3

18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

CompletedNCT00103649

SanofiAlzheimer Disease

Start: 2003-11-30End: 2007-10-31Updated: 2008-08-21

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

CompletedNCT00104013

SanofiAlzheimer Disease

Start: 2003-11-30End: 2007-11-30Updated: 2008-08-21

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

CompletedNCT00305188

SanofiColorectal Carcinoma, Colorectal Neoplasms, Metastases

Start: 2005-12-31End: 2009-10-31Updated: 2016-05-04

Related Papers

Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer

American Journal of Clinical Oncology2022-12-262 citations

Outcomes of Patients With Advanced Gastrointestinal Cancer in Relationship to Opioid Use: Findings From Eight Clinical Trials

Journal of the National Comprehensive Cancer Network2020-05-0110 citations

Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials.

2020-02-0113 citations

Outcomes of advanced gastrointestinal (GI) cancer patients in relationship to opioid use: An individual patient data pooled analysis from eight clinical trials.

Journal of Clinical Oncology2020-02-011 citations

ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.

2019-11-1622 citations

Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.

2019-09-0617 citations

Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials.

2019-07-1524 citations

Predictors of toxicity-related hospitalization in four randomized studies of 5-fluorouracil-based chemotherapy in metastatic colorectal cancer.

2019-01-248 citations

Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials.

2018-12-2833 citations

5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer.

2018-11-0130 citations

Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies.

2018-09-0411 citations

Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.

2018-08-201 citations